西维斯健康(CVS)
搜索文档
The 3 Most Undervalued S&P 500 Stocks to Buy in February 2024
InvestorPlace· 2024-02-07 10:41
投资标准普尔500指数的公司股票可能带来长期盈利 - 投资标准普尔500指数的公司股票可能带来长期盈利[1] - 投资被低估的标准普尔500指数股票可能带来丰厚回报[2] - 投资大型市值巨头可能比投资热门股票更有利[3] LyondellBasell (LYB)公司股票分析 - LyondellBasell (LYB)公司的股票被低估,目前交易价格仅为未来收益的9.82倍[5] - 分析师认为LyondellBasell (LYB)是一家中等买入的股票,平均目标价格为103.67美元[7] CVS Health (CVS)公司股票分析 - CVS Health (CVS)公司的股票交易价格为未来收益的8.6倍,被认为是被低估的标准普尔500指数股票之一[12] General Motors (GM)公司股票分析 - General Motors (GM)公司的股票交易价格为未来收益的5.05倍,被认为是被低估的标准普尔500指数股票之一[16]
CVS Health(CVS) - 2023 Q4 - Annual Report
2024-02-07 00:00
公司业务 - 公司拥有超过9000家零售店,1000多家医疗诊所,204家初级医疗诊所[13] - 公司在2023年完成了两项关键的医疗资产收购,以增强其在护理交付战略上的执行能力[14] - 公司于2023年3月29日收购了Signify Health, Inc.和Oak Street Health, Inc.[15] - 公司有四个可报告部门:医疗保健福利、健康服务、药房与消费者健康以及企业/其他[17] 未来展望 - 公司强调了未来的前景和展望,包括2024年的展望、市场风险的定量和定性披露、政府监管和风险因素等[8] 市场扩张和并购 - 公司在2023年第一季度采用了新的运营模式,重新调整了各部门的构成,形成了新的健康服务部门和药房与消费者健康部门[16] - 公司通过Oak Street Health初级保健中心提供全面的初级保健服务,帮助独立的卫生系统过渡到以价值为基础的护理[82] 新产品和新技术研发 - 公司的NovoLogix®在线预授权工具有助于识别和捕捉在医疗保险福利下计费的特殊药物的成本节约机会[79] - 公司提供多种临床方案和服务,旨在帮助客户以临床适当的方式管理整体药房和医疗保健成本[76]
The 7 Most Undervalued Large-Cap Stocks to Buy in February 2024
InvestorPlace· 2024-02-06 19:35
大市值股票关注点 - "Magnificent Seven"股票吸引了市场关注,但也应关注少有报道的低估大市值股票[1] - 大市值价值股可能存在“价值陷阱”,但也有潜力的股票存在[2] 大市值股票获胜方式 - 大市值价值股可能通过三种方式获胜:重新定价、盈利增长和股息支付[3]
Exploring Analyst Estimates for CVS Health (CVS) Q4 Earnings, Beyond Revenue and EPS
Zacks Investment Research· 2024-02-02 23:21
Wall Street analysts forecast that CVS Health (CVS) will report quarterly earnings of $2 per share in its upcoming release, pointing to a year-over-year increase of 0.5%. It is anticipated that revenues will amount to $90.46 billion, exhibiting an increase of 7.9% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed the ...
CVS Health (CVS) Earnings Expected to Grow: Should You Buy?
Zacks Investment Research· 2024-02-01 00:05
The market expects CVS Health (CVS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2023. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released ...
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
Zacks Investment Research· 2024-01-30 23:06
CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this drugstore chain and pharmacy benefits manager have returned -6.9%, compared to the Zacks S&P 500 composite's +3.4% change. During this period, the Zacks Retail - Pharmacies and Drug Stores industry, which CVS Health falls in, has lost 7.5%. The key question now is: What could be the sto ...
Is the Worst Over for CVS Health Stock?
Schaeffers Research· 2024-01-30 04:49
股价表现 - CVS Health Corp (NYSE:CVS) 股价上涨至 $73.40,距离 $70 的反弹[1] - CVS 股价目前处于80日趋势线的一个标准偏差之内,过去三年内出现了至少五个类似信号[2] - 在过去的类似情况中,CVS 股价一个月后有80%的概率上涨,平均涨幅为3.9%[4]
CVS Health (CVS) Advances While Market Declines: Some Information for Investors
Zacks Investment Research· 2024-01-27 07:51
The latest trading session saw CVS Health (CVS) ending at $73, denoting a +1.4% adjustment from its last day's close. The stock's performance was ahead of the S&P 500's daily loss of 0.07%. On the other hand, the Dow registered a gain of 0.16%, and the technology-centric Nasdaq decreased by 0.36%.Shares of the drugstore chain and pharmacy benefits manager have depreciated by 8.84% over the course of the past month, underperforming the Retail-Wholesale sector's gain of 1.02% and the S&P 500's gain of 3.05%.T ...
CVS Health adds two new renewable energy projects with Constellation
Prnewswire· 2024-01-25 21:00
CVS Health与Constellation达成两项协议 - CVS Health宣布与Constellation达成两项协议,总计264,000兆瓦时,购买零排放、可再生能源[2] - 这两项投资将使公司的碳足迹每年减少近114,000公吨[2] - CVS Health将通过与Constellation的两项长期协议购买能源和可再生能源证书(RECs)[4] CVS Health的可再生能源投资 - CVS Health自2022年以来已进行了五项可再生能源投资,总计超过500,000兆瓦时的清洁可再生能源[7] - 这占据了CVS Health在2022年使用的2.2百万兆瓦时能源的重要份额[7]
Tyson Foods drops CVS for upstart pharmacy benefit manager, as industry upheaval over cost concerns spreads
CNBC· 2024-01-24 22:18
Tyson Foods will become one of the first Fortune 100 companies to stop using the nation's traditional large pharmacy benefits managers, as it looks to cut spending on high-cost drugs. After putting its benefits contract up for bid, Tyson dropped CVS Health's Caremark and chose PBM startup Rightway to manage drug benefits for its 140,000 employees starting this year, the companies said Wednesday. Rightway guarantees that it can save employers 15% on pharmacy costs by using a transparent model where it pass ...